IRLAB Therapeutics AB (OSTO:IRLAB A) Price-to-Operating-Cash-Flow : (As of Dec. 14, 2024)

View and export this data going back to 2017. Start your Free Trial

What is IRLAB Therapeutics AB Price-to-Operating-Cash-Flow?

As of today (2024-12-14), IRLAB Therapeutics AB's share price is kr11.40. IRLAB Therapeutics AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was kr-1.52. Hence, IRLAB Therapeutics AB's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for IRLAB Therapeutics AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 11 years, IRLAB Therapeutics AB's highest Price-to-Operating-Cash-Flow Ratio was 19.08. The lowest was 12.27. And the median was 16.65.

OSTO:IRLAB A's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.685
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

IRLAB Therapeutics AB's Cash Flow from Operations per share for the three months ended in Sep. 2024 was kr-0.13. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was kr-1.52.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -19.30% per year.

During the past 11 years, IRLAB Therapeutics AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was -3.60% per year. The lowest was -54.90% per year. And the median was -14.75% per year.

IRLAB Therapeutics AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for IRLAB Therapeutics AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IRLAB Therapeutics AB Price-to-Operating-Cash-Flow Chart

IRLAB Therapeutics AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

17.70

IRLAB Therapeutics AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of IRLAB Therapeutics AB's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, IRLAB Therapeutics AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IRLAB Therapeutics AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IRLAB Therapeutics AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where IRLAB Therapeutics AB's Price-to-Operating-Cash-Flow falls into.

IRLAB Therapeutics AB Price-to-Operating-Cash-Flow Calculation

IRLAB Therapeutics AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	11.40	/	-1.52
	=

IRLAB Therapeutics AB's Share Price of today is kr11.40.
IRLAB Therapeutics AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.52.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

IRLAB Therapeutics AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of IRLAB Therapeutics AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

IRLAB Therapeutics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IRLAB Therapeutics AB (OSTO:IRLAB A) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

6IRA:Germany

Address

Arvid Wallgren Backe 20, Goteborg, SWE, 413 46

Website

https://www.irlab.se

IRLAB Therapeutics AB is a drug discovery and development company providing novel treatments for disorders of the brain. The company focuses on innovative treatments and quality of life for patients with neurological and psychiatric illnesses. It is engaged in programs targeting core dysfunctions in Parkinson's disease and dementias. In addition, it is also involved in the clinical development of novel compounds which aims at offering improved clinical benefit for patients with Parkinson's disease. The company's current clinical candidates, mesdopetam (IRL790) and pirepemat (IRL752), both of which have successfully gone through Phase I safety and Phase IIa efficacy proof-of-concept studies, are now in Phase IIb trials.

IRLAB Therapeutics AB Headlines

No Headlines